De Novo Malignancy Risk in Patients Undergoing the First Percutaneous Coronary Intervention: A nationwide population-based cohort study

[Speaker] Soongu Kwak,Korea
¹Soongu Kwak, ¹You-Jung Choi, ¹Soonil Kwon, ¹Seo-Young Lee, ¹Seokhun Yang, ¹Inki Moon, ¹Hyun-Jung Lee, ^1,2Heesun Lee, ¹Jun-Bean Park, ³Kyungdo Han, ¹Yong-Jin Kim, ¹Hyung-Kwan Kim
¹Department of Internal medicine, Seoul National University Hospital, Seoul, Korea ²Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea ³Department of Biostatistics, The Catholic University of Korea, Seoul, Korea

Hypertensive disease burden in Adult Patients with Cancer: An 11-Year Nationwide Population-Based Cohort Study

[Speaker] Eui-Soon Kim,Korea
Eui-Soon Kim¹, Jong-Chan Youn², Hyewon Nam³, Dae-Sung Kyoung³, Jin-Jin Kim², Ami Kwon², Woo-Baek Chung², Hae Ok Jung², Ho-Joong Youn², Sang Hong Baek^2
1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea, ²Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, ³Data Science Team, Hanmi Pharm. Co., Ltd., Seoul, Republic of Korea

Risk score Model for Predicting Cardiovascular Outcome after Breast Cancer Therapy: The CHEMO-RADIT score

[Speaker] Do Young Kim,Korea
Do Young Kim¹, Jong-Chan Youn², Myung-Soo Park¹, Sunki Lee¹, Jae Hyuk Choi¹, Mi-Hyang Jung¹, Kyu-Hyung Ryu¹, Lee Su Kim³, and Seongwoo Han^1
1Division of Cardiology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.²Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ³Division of Breast and Endocrine Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea

The role of epicardial adipose tissue in development of chemotherapy induced cardiotoxicity in breast cancer patients

[Speaker] Mi-Na Kim,Korea
Mi-Na Kim¹, MD, PhD, Seong-Mi Park¹, MD, PhD, Sung-A Bae¹, MD, So-Ri Kim¹, MD, Seung Pil Jung², MD, PhD, Kyong Hwa Park³, MD, PhD, Wan-Joo Shim¹, MD, PhD
¹ Division of Cardiology, Korea University Medical Center, Anam Hospital, Seoul, Korea ² Division of Breast and Endocrine Surgery, Korea University Medical Center, Anam Hospital, Seoul, Korea ³ Division of Oncology, Korea University Medical Center, Anam Hospital, Seoul, Korea